Went long Regeneron Pharmaceuticals Inc. stock (REGN) on September 19, 2017 at $431.60/share (previously discussed in the September 18, 2017 newsletter issue); on September 20, 2017, sold REGN at $438.17/share generating a 1.5% return. Subscribe now to discover when and how to seize consistently profitable opportunities like this no matter what the market does.